{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T16:35:44Z","timestamp":1759941344496},"reference-count":22,"publisher":"Medical Association of Nippon Medical School","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nippon Med Sch"],"published-print":{"date-parts":[[2018,10,15]]},"DOI":"10.1272\/jnms.jnms.2018_85-46","type":"journal-article","created":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T22:41:27Z","timestamp":1542753687000},"page":"287-290","source":"Crossref","is-referenced-by-count":8,"title":["Valproate-Induced Polycystic Ovary Syndrome in a Girl with Epilepsy: A Case Study"],"prefix":"10.1272","volume":"85","author":[{"given":"Yasuhiko","family":"Kawakami","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Nippon Medical School Musashi Kosugi Hospital"},{"name":"Department of Pediatrics, Nippon Medical School Tama Nagayama Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuichi","family":"Fujii","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nippon Medical School Tama Nagayama Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gen","family":"Ishikawa","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Nippon Medical School Chiba Hokusoh Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuko","family":"Sekiguchi","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Nippon Medical School Tama Nagayama Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihito","family":"Nakai","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Nippon Medical School Tama Nagayama Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Takase","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nippon Medical School Tama Nagayama Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"21","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Isoj\u00e4rvi JI, Laatikainen TJ, Pakarinen AJ, Juntunen KT, Myllyl\u00e4 VV: Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. N Engl J Med 1993; 329: 1383-1388.","DOI":"10.1056\/NEJM199311043291904"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Ehrmann DA: Polycystic ovary syndrome. N Engl J Med 2005; 352: 1223-1236.","DOI":"10.1056\/NEJMra041536"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Niki H, Matsuzaki T, Kinouchi R, Iwasa T, Kawami T, Kato T, Kuwahara A, Irahara M: Improvement in diagnostic performance of the revised total testosterone measuring system in Japanese women with polycystic ovary syndrome. J Med Invest 2014; 61: 65-71.","DOI":"10.2152\/jmi.61.65"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Stein IF, Leventhal ML: Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 1935; 29: 181-191.","DOI":"10.1016\/S0002-9378(15)30642-6"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Asunci\u00f3n M, Calvo RM, San Mill\u00e1n JL, Sancho J, Avila S, Escobar-Morreale HF: A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 2000; 85: 2434-2438.","DOI":"10.1210\/jc.85.7.2434"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R: Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 1998; 83: 3078-3082.","DOI":"10.1210\/jc.83.9.3078"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Bilo L, Meo R: Polycystic ovary syndrome in women using valproate: a review. Gynecol Endocrinol 2008; 24: 562-570.","DOI":"10.1080\/09513590802288259"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Verrotti A, D'Egidio C, Mohn A, Coppola G, Parisi P, Chiarelli F: Antiepileptic drugs, sex hormones, and PCOS. Epilepsia 2011; 52: 199-211.","DOI":"10.1111\/j.1528-1167.2011.03310.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Herzog AG, Seibel MM, Schomer DL, Vaitukaitis JL, Geschwind N: Reproductive endocrine disorders in women with partial seizures of temporal lobe origin. Arch Neurol 1986; 43: 341-346.","DOI":"10.1001\/archneur.1986.00520040029014"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Mikkonen K, Vainionp\u00e4\u00e4 LK, Pakarinen AJ, Knip M, J\u00e4rvel\u00e4 IY, Tapanainen JS, Isoj\u00e4rvi JI: Long-term reproductive endocrine health in young women with epilepsy during puberty. Neurology 2004; 62: 445-450.","DOI":"10.1212\/01.WNL.0000106942.35533.62"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Hu X, Wang J, Dong W, Fang Q, Hu L, Liu C: A meta-analysis of polycystic ovary syndrome in women taking valproate for epilepsy. Epilepsy Res 2011; 97: 73-82.","DOI":"10.1016\/j.eplepsyres.2011.07.006"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Conway GS, Agrawal R, Betteridge DJ, Jacobs HS: Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome. Clin Endocrinol 1992; 37: 119-125.","DOI":"10.1111\/j.1365-2265.1992.tb02295.x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Wild RA, Painter PC, Coulson PB, Carruth KB, Ranney GB: Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1985; 61: 946-951.","DOI":"10.1210\/jcem-61-5-946"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Wild RA, Applebaum-Bowden D, Demers LM, Bartholomew M, Landis JR, Hazzard WR, Santen RJ: Lipoprotein lipids in women with androgen excess: Independent associations with increased insulin and androgen. Clin Chem 1990; 36: 283-289.","DOI":"10.1093\/clinchem\/36.2.283"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Wild RA, Grubb B, Hartz A, Van Nort JJ, Bachman W, Bartholomew M: Clinical signs of androgen excess as risk factors for coronary artery disease. Fertil Steril 1990; 54: 255-259.","DOI":"10.1016\/S0015-0282(16)53699-1"},{"key":"16","unstructured":"16. Ribacoba-Montero R, Maitfnez-Faedo C, DiazDfaz C, Salas-Puig J: Remission of polycystic ovary syndrome associated with valproic acid in an epileptic female. Rev Neurol 2003; 36: 639-642."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Joffe H, Cohen LS, Suppes T, Hwang CH, Molay F, Adams JM, Sachs GS, Hall JE: Longitudinal follow-up of reproductive and metabolic features of valproate-associated polycystic ovarian syndrome features: A preliminary report. Biol Psychiatry 2006; 60: 1378-1381.","DOI":"10.1016\/j.biopsych.2006.05.027"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Tomson T: Commentary: Valproate in the treatment of epilepsy in women and girls: The need for recommendations. Epilepsia 2015; 56: 1004-1005.","DOI":"10.1111\/epi.13036"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Isoj\u00e4rvi JI, R\u00e4tty\u00e4 J, Myllyl\u00e4 VV, Knip M, Koivunen R, Pakarinen AJ, Tekay A, Tapanainen JS: Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy. Ann Neurol 1998; 43 (4): 446-451.","DOI":"10.1002\/ana.410430406"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Pope HG Jr, McElroy SL, Keck PE Jr, Hudson JI: Valproate in the treatment of acute mania. A placebo-controlled study. Arch Gen Psychiatry 1991; 48: 62-68.","DOI":"10.1001\/archpsyc.1991.01810250064008"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Evers S, Afra J, Frese A, Goadsby PJ, Linde M, May A, S\u00e1ndor PS: European Federation of Neurological Societies. EFNS guideline on the drug treatment of migraine--revised report of an EFNS task force. Eur J Neurol 2009; 16: 968-981.","DOI":"10.1111\/j.1468-1331.2009.02748.x"},{"key":"22","unstructured":"22. Minagawa K, Watanabe T, Oyanagi R: Characteristics of women with epilepsy who developed polycystic ovary syndrome owing to the therapy with valproate sodium. No To Hattatsu 2013; 45: 304-308(in Japanese)."}],"container-title":["Journal of Nippon Medical School"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/85\/5\/85_JNMS.2018_85-46\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,15]],"date-time":"2020-11-15T17:11:16Z","timestamp":1605460276000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/85\/5\/85_JNMS.2018_85-46\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,15]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1272\/jnms.jnms.2018_85-46","relation":{},"ISSN":["1345-4676","1347-3409"],"issn-type":[{"value":"1345-4676","type":"print"},{"value":"1347-3409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,15]]}}}